ANGIOMET: Analysis of the correlations between angiogenic markers and outcome in patients (p) with advanced nonsquamous NSCLC (NS-NSCLC) treated with carboplatin, paclitaxel, and bevacizumab (CPB).

Bartomeu Massuti,Eloisa Jantus-Lewintre,Jose Luis Gonzalez Arriba,Delvys Rodriguez Abreu,O Juan,Manuel Domine,Mariano Provencio,J. Garde,Ramón García Gómez,I. Maestu,Ramon Maria Perez Carrion,A. Artal,Christian Rolfo,J. Terrasa,Juana Oramas,Ramon De Las Penas,Maria Sanchez Ronco,Javier Castro,Rafael Rosell,Carlos Camps

ANGIOMET: Analysis of the correlations between angiogenic markers and outcome in patients (p) with advanced nonsquamous NSCLC (NS-NSCLC) treated with carboplatin, paclitaxel, and bevacizumab (CPB).

2014

e19014 Background: In NS-NSCLC CPB achieved median OS > 1 y and supported use of B. A broad range of predictive/prognostic markers explored for B use. In VEGF pathway ligands and receptors play an ...

Keywords:

Carboplatin/paclitaxel
Bevacizumab
Pathology
Oncology
Medicine
Internal medicine
vegf pathway
Receptor
in patient

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations